Cell phone bans, dress code changes – in some cases banning hoodies and all-black clothing – and even the removal of mirrors from school bathrooms are among the changes schools across America ...

GSK confirmed this morning that the disappointing readout from the DREAMM-3 trial of multiple myeloma therapy Blenrep reported earlier this month means that it will take the drug off the US market.

(Alliance News) - GSK PLC on Wednesday announced progress in Japan on treating chronic hepatitis B and chronic rhinosinusitis with nasal polyps, while it welcomed a decision by the Delaware ...

MRNA-1403 is under clinical development by Moderna and currently in Phase II for Norovirus Infections. According to GlobalData, Phase II drugs for Norovirus Infections does not have sufficient ...

The company's oncology portfolio, consisting of Zejula, Blenrep, Jemperli, and Ojjaara/Omjjara, reported total sales of $450 million in the second quarter of 2024, up 136.8% year-on-year and 30.1% ...

Wall Street futures were slightly higher ahead of the bell on Monday as market participants cheered news that the Federal Reserve appeared to be on the cusp of making interest rate cuts. As of ...

Prepare to wear your hoodies beyond the gym. Having a plain black hoodie in your wardrobe is absolutely necessary in my opinion. Not only will you wear it a million times (and so many different ...

Recent data showed a benefit when using a BLENREP (belantamab mafodotin) in relapsed or refractory multiple myeloma across all pre-specified subgroups of patients, including those with unfavorable ...

In June 2024, BioWorld covered 221 clinical trial updates, compared to 298 in May. BioWorld recorded 23 phase III trial successes in June, seven failures, and one with mixed results.

GSK has great expectations for its BCMA-directed cancer drug Blenrep, but a failed phase 3 trial in relapsed or refractory multiple myeloma has raised doubts about its prospects – and even the ...